Millie
your market intelligence analyst
Search Results
402 results
Your search is now limited to «Diabetes Clinical Trials» expert search.
FeedNavigator (EU) 09/17/2019 10:07
Table 9 Multifactorial logistic regression analysis of occurrence of vision-threatening diabetic retinopathy among all diabetic patients Questionnaire The participants with DM completed a questionnaire for lifestyle and medical conditions, and the content and results of the questionnaire are summarised in online supplementary file 2.
More from FeedNavigator (EU):
PR Newswire 09/17/2019 08:40
Topline data from the primary cohort of the Phase IIb trial are expected to be released in the fourth quarter of 2019.
More from PR Newswire:
GlobeNewswire 09/17/2019 07:00
The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, expected to advance into a Phase 1 study in 2020.
More from GlobeNewswire:
Diabetes In Control News 09/16/2019 20:06
Previous phase 2 studies have demonstrated the impaired absorption of oral glucose lowering therapies with food, leading to the administration of study drugs during a fasted state with adequate amounts of water and prior to administration of any other oral medication throughout this trial ...
More from Diabetes In Control News:
Healio News 09/16/2019 12:49
As Healio previously reported, in the DAPA-HF trial presented at the European Society of Cardiology Congress, dapagliflozin reduced risk for CV death or HF worsening when added to standard therapy in patients with HFrEF with or without diabetes.
More from Healio News:
Business Wire 09/16/2019 11:40
The results of the Phase IIA international randomized, placebo-controlled study showed that in patients with prediabetes, TOTUM-63 reduces fasting blood glucose and blood glucose at 2 hours, two risk factors of type 2 diabetes.
More from Business Wire:
In addition, studies focusing on the primary prevention or treatment of gestational diabetes, or the immediate pregnancy outcomes of women with diabetes are not within NIDDKs mission, and will not be considered for funding through this initiative.
More from National Institutes of Health (NIH):
Seeking Alpha 09/12/2019 05:35
The settlement calls for Lexicon to regain all worldwide rights to Zynquista in both Type 1 and Type 2 diabetes, with Sanofi helping to transition the ongoing clinical studies to Lexicon’s control, as well as transitioning ownership of the relevant regulatory filings (NDAs, MAAs, etc.
More from Seeking Alpha:
ClinicalTrials.gov 09/09/2019 10:19
Condition : Diabetic Neuropathy Interventions : Drug: BOL-DP-o-04; Drug: Placebo Sponsor : Breath of Life International Pharma Ltd Recruiting.
More from ClinicalTrials.gov:
Bio-Medicine.Org 09/09/2019 05:05
AMERSHAM, U.K. and MALVERN, Pa. (PRWEB) September 09, 2019 This Autumn Phlexglobal will host the annual TMF World Forum, two exciting events focused on helping the life science industry, including pharmaceutical companies, clinical research organizations, and medical device manufacturers, mee...
More from Bio-Medicine.Org:
Preclinical study has demonstrated improvement in cognitive function by VDBP via inhibiting synaptic degeneration.
More from International Journal of COPD:
PharmiWeb.com 09/05/2019 23:34
Initial preclinical work in animal models of diabetes has shown that transplantation of these cells by infusion into the liver is sufficient to control blood glucose levels.
More from PharmiWeb.com:
ENDPOINTS 09/04/2019 08:46
Vertex’s $950 million cash deal to buy Semma and its preclinical stem cell program for diabetes — shooting for a potential cure that combines insulin-producing cells inside a “tea bag” tech for preventing them from sparking an immune response — shot straight to the top of the list of the biggest acquisitions ...
More from ENDPOINTS:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications